Pancreastatin: A Predictive Neuroendocrine Tumor Marker

#591

Introduction: Pancreastatin is a derived peptide of CgA. Pancreastatin has the potential to be a diagnostic and predictive tumor marker in detecting NETs.

Aim(s): To compare the predictive value of pancreastatin to CgA for identifying patients with NETs.

Materials and methods: Radioimmunoassay tests of pancreastatin and CgA were performed on 103 patient specimens collected from Mount Sinai Medical Center between 1/2010 and 7/2012. Patient demographics, diagnostic tests, surgical procedures, pathologic findings, adjuvant treatments, and survival were retrospectively reviewed. Statistical analysis utilized SPSS v20 software.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Rustagi S, Warner R, Divino C,

Keywords: pancreastatin, NETs, CgA,

To read the full abstract, please log into your ENETS Member account.